Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and …

G Liguori, C Trombetta, G De Giorgi… - The journal of sexual …, 2009 - academic.oup.com
ABSTRACT Introduction Alpha1-blockers (AB) are the first-line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line …

Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract Symptoms …

G Liguori, C Trombetta, G De Giorgi… - The Journal of …, 2009 - Wiley Online Library
ABSTRACT Introduction. Alpha1‐blockers (AB) are the first‐line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first‐line …

[PDF][PDF] Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract …

G Liguori, C Trombetta, MD Gioacchino De Giorgi… - 2008 - academia.edu
ABSTRACT Introduction. Alpha1-blockers (AB) are the first-line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line …

Efficacy and Safety of Combined Oral Therapy with Tadalafil andAlfuzosin: An Integrated Approach to the Management of Patientswith Lower Urinary Tract Symptoms …

G LIGUORI, C TROMBETTA, G De Giorgi, G Pomara… - 2009 - ricerca.unityfvg.it
Abstract INTRODUCTION: Alpha1-blockers (AB) are the first-line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line …

Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract Symptoms …

G Liguori, C Trombetta, G De Giorgi, G Pomara… - The Journal of Sexual …, 2009 - Elsevier
ABSTRACT Introduction Alpha1-blockers (AB) are the first-line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line …

[引用][C] Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract …

G LIQUORI - J. Sex. Med., 2009 - cir.nii.ac.jp
Efficacy and safety of combined oral therapy with tadalafil and alfuzosin : an integrated
approach to the management of patients with lower urinary tract symptoms and erectile …

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and …

G Liguori, C Trombetta, G De Giorgi, G Pomara, G Maio… - 2009 - pubmed.ncbi.nlm.nih.gov
Introduction Alpha1-blockers (AB) are the first-line monotherapy for lower urinary tract
symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line treatment for …

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and …

G Liguori, C Trombetta, G De Giorgi… - The Journal of Sexual …, 2008 - europepmc.org
Aim The aim was to evaluate the efficacy of a combined therapy with an AB (alfuzosin) and
PDE5 inhibitors (tadalafil) in patients with LUTS and ED. Methods This was a randomized …

Efficacy and Safety of Combined Oral Therapy with Tadalafil andAlfuzosin: An Integrated Approach to the Management of Patientswith Lower Urinary Tract Symptoms …

G Liguori, C Trombetta, G De Giorgi, G Pomara… - JOURNAL OF SEXUAL …, 2009 - arts.units.it
INTRODUCTION: Alpha1-blockers (AB) are the first-line monotherapy for lower urinary tract
symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line treatment for …

[PDF][PDF] Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract …

G Liguori, C Trombetta, MD Gioacchino De Giorgi… - J Sex Med, 2008 - academia.edu
ABSTRACT Introduction. Alpha1-blockers (AB) are the first-line monotherapy for lower
urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line …